PO-0682 OUTCOMES FOLLOWING PERMANENT BRACHYTHERAPY IN JAPANESE PATIENTS WITH INTERMEDIATE-RISK PROSTATE CANCER
Norihisa Katayama(Okayama University), S. Kanazawa(National Hospital Organization), Kensuke Bekku(Okayama University), Takahiro Waki(Okayama Medical Center), Toshiyuki Ogata(Kyoto Prefectural University of Medicine), Mitsuhiro Takemoto(Okayama University), S. Ebara(Okayama University Hospital), Ryuta Tanimoto(Okayama University), Y. Nasu, Kuniaki Katsui(Fukuyama City Hospital)
Cited by 0
Related Papers
Pretreatment prognostic nutritional index is a significant predictor of prognosis in patients with cervical cancer treated with concurrent chemoradiotherapy
|Molecular and Clinical Oncology|2016|79
Carbon Ion Irradiation Suppresses Metastatic Potential of Human Non-small Cell Lung Cancer A549 Cells through the Phosphatidylinositol-3-Kinase/Akt Signaling Pathway
|Journal of Radiation Research|2011|71
Analysis of Factors Associated With Radiation-Induced Bronchiolitis Obliterans Organizing Pneumonia Syndrome After Breast-Conserving Therapy
|International Journal of Radiation Oncology*Biology*Physics|2008|69
REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer
|International Journal of Molecular Medicine|2007|63
Urinary and Rectal Toxicity Profiles After Permanent Iodine-125 Implant Brachytherapy in Japanese Men: Nationwide J-POPS Multi-institutional Prospective Cohort Study
|International Journal of Radiation Oncology*Biology*Physics|2015|43